Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting metabolic dependencies in JAK2-V617F-driven MPNs.

Blood advances - 14 May 2024

Wolf Dominik, Pircher Andreas

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to JAK2 gene
Share to Janus Kinase 2
Share to Molecular Targeted Therapy
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 38743413
DOI: 10.1182/bloodadvances.2024012837
PMCID: PMC11116987

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting metabolic dependencies in JAK2-V617F-driven MPNs.PMID 38743413Read ↗

Clearing the path for MPN therapy monitoring.Semantic proximity Read ↗

Mutations in MPNs to "interfere-on".Semantic proximity Read ↗

How to Sequence Therapies in Waldenström Macroglobulinemia.Semantic proximity Read ↗

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms.Semantic proximity Read ↗

JAK2 mutations other than V617F: a novel mutation and mini review.Semantic proximity Read ↗

Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines.Semantic proximity Read ↗

Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle.Semantic proximity Read ↗

Challenges Facing JAK Inhibitor Therapy for Myeloproliferative NeoplasmsSemantic proximity Read ↗

JAK2 inhibitors in myelofibrosis.Semantic proximity Read ↗

CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networksSemantic proximity Read ↗

Mapping m6A and m1A with mutation signatures.Semantic proximity Read ↗

Acquisition of JAK2 V617F to CALR-mutated clones accelerates disease progression and might enhance growth capacity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.